VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 51 filers reported holding VERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,281,708 | +49618.1% | 453,689 | -76.0% | 0.00% | -50.0% |
| Q1 2023 | $14,646 | -31.7% | 1,887,351 | +70.2% | 0.01% | -33.3% |
| Q4 2022 | $21,452 | -99.7% | 1,108,649 | +179.3% | 0.01% | +140.0% |
| Q3 2022 | $8,459,000 | +125.0% | 396,928 | +43.7% | 0.01% | +150.0% |
| Q2 2022 | $3,760,000 | +19.9% | 276,243 | +106.9% | 0.00% | 0.0% |
| Q1 2022 | $3,136,000 | +190.6% | 133,500 | +63.9% | 0.00% | +100.0% |
| Q2 2021 | $1,079,000 | – | 81,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |